⚕ GalenOps CRO console
← 701 (USA)

701-1188

completed
Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. Phase II · Site: 701 (USA) (Dr. Reyes) · consented 2013-02-15
Adverse events
8
Serious AEs
0
Open data queries
0
Luna dropout signal
–

Adverse events

mild assessed 2026-08-18

Mild APPLICATION SITE URTICARIA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-03-21 (study day 35.0); relationship: PROBABLE

mild assessed 2026-08-18

Mild ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-02-16 (study day 2.0); relationship: PROBABLE

moderate assessed 2026-08-18

Moderate ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-02-16 (study day 2.0); relationship: PROBABLE

mild assessed 2026-08-18

Mild PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-02-16 (study day 2.0); relationship: PROBABLE

moderate assessed 2026-08-18

Moderate PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-02-16 (study day 2.0); relationship: PROBABLE

mild assessed 2026-08-18

Mild URTICARIA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-03-04 (study day 18.0); relationship: PROBABLE

moderate assessed 2026-08-18

Moderate URTICARIA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-03-04 (study day 18.0); relationship: PROBABLE

mild assessed 2026-08-18

Mild URTICARIA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-03-21 (study day 35.0); relationship: PROBABLE

Data queries

No data queries.

☾ Luna engagement

This participant doesn't use Luna.